Free CCSPA test prep and VCE Exam Cram

Being prepared for CCSPA exam is very easy if you apply at and download CCSPA Questions and Answers files in your smartphone or iPad or laptop, Install CCSPA VCE exam simulator in your computer and go out for at least 24 hours break. Take your time to study CCSPA Questions and Answers. Practice with VCE exam simulator and give it a try in real CCSPA exam. You will please to see that all real CCSPA questions come from these test prep.

Exam Code: CCSPA Practice test 2022 by team
Check Point Certified Security Principles Associate CCSPA
Checkpoint Principles study tips
Killexams : Checkpoint Principles study tips - BingNews Search results Killexams : Checkpoint Principles study tips - BingNews Killexams : Here are things you cannot bring through a TSA checkpoint

What you need to know ahead of the busy travel season and security at airports.

ST. LOUIS — It's a busy travel season and airport security officials want people to remember which items are prohibited from carry-on luggage.

The Transportation Security Administration runs airport checkpoints and has tips for air travelers. The TSA wants people to know that the final decision on items "rests with the TSA officer on whether an item is allowed through the checkpoint."

If you are traveling with gifts, make sure they aren't wrapped in wrapping paper.

Here are some of the items that cannot be brought through security or in a carry-on bag.

Prohibited through checkpoints

  • Alcoholic beverages over 140 proof
  • Ammunition
  • Baseball bats, canoe paddles, hockey sticks or other long and thin sports equipment
  • Bottled water - 3.4 ounces or less is permitted
  • Bowling pins
  • Box cutters
  • Cooking spray
  • Crowbars
  • English Christmas Crackers
  • Foam toy sword
  • Golf clubs
  • Hammers
  • Liquids greater than 3.4 ounces, with a few exceptions
  • Magic 8 Ball
  • Pepper spray, pocket knives, any weapon
  • Samsung Galaxy Note 7
  • Scissors longer than 4 inches from the pivot point
  • Sparklers

For the full list of items and exceptions, check out the TSA's website. Many of the items above may be transported in a checked bag.

Liquids and creams must be in travel-sized containers that are 3.4 ounces or less per item. The items must fit in one quart-sized resealable bag. There are medical exceptions and exceptions for liquids for infants and children.

Thu, 08 Dec 2022 06:00:00 -0600 en-US text/html
Killexams : VPD conducting a DUI checkpoint this month

The Vallejo Police Department has announced it will conduct a driving under the influence (DUI) Checkpoint on Dec. 16 from 6 p.m. to 2 a.m. at an undisclosed location.

The news release by the VPD states that “DUI checkpoint locations are determined based on data showing incidents of impaired driving-related crashes. The primary purpose of DUI checkpoints are to promote public safety by taking suspected impaired drivers off the road.”

“Impaired drivers put others on the road at significant risk,” Sgt. Rashad Hollis said in the same news release. “Any prevention measures that reduce the number of impaired drivers on our roads significantly improves traffic safety.”

In the statement, the VPD reminds the public that impaired driving is not just from alcohol. Some prescription medications and over-the-counter drugs may interfere with driving. While medicinal and recreational marijuana are legal, driving under the influence of marijuana is illegal.

Drivers charged with a first-time DUI face an average of $13,500 in fines and penalties, as well as a suspended license.

Funding for this program was provided by a grant from the California Office of Traffic Safety, through the National Highway Traffic Safety Administration.

Fri, 02 Dec 2022 07:29:00 -0600 Vallejo Times-Herald en-US text/html
Killexams : Checkpoint Therapeutics falls 8.6% on 1-for-10 reverse stock split

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Mon, 05 Dec 2022 02:55:00 -0600 en text/html
Killexams : Checkpoint Therapeutics Announces Reverse Stock Split

Checkpoint Therapeutics, Inc

WALTHAM, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it will effect a 1-for-10 reverse stock split of its issued and outstanding common stock. Checkpoint expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on December 6, 2022.

The reverse stock split was approved on November 3, 2022 by Checkpoint’s Board of Directors and stockholders representing approximately 58% of the voting power of Checkpoint’s outstanding capital stock. The reverse stock split is intended to Boost the marketability and liquidity of Checkpoint’s common stock and to remain in compliance with Nasdaq’s continued listing requirements.

Checkpoint’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “CKPT” following the reverse stock split, with a new CUSIP number of 162828206. The reverse stock split will affect all stockholders uniformly and will not alter any stockholder's percentage interest in Checkpoint’s equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share. No fractional shares will be issued in connection with the reverse stock split and stockholders who would otherwise be entitled to a fractional share will receive a proportional cash payment. After the effectiveness of the reverse stock split, the number of outstanding shares of common stock will be reduced from approximately 93 million to approximately 9.3 million.

Checkpoint’s transfer agent, VStock Transfer, LLC, is also acting as the exchange and paying agent for the reverse stock split. VStock Transfer, LLC will provide instructions to stockholders regarding the process for exchanging physical share certificates. Checkpoint does not expect that stockholders holding their shares in book-entry form or through a bank, broker or other nominee need to take any action in connection with the reverse stock split. Beneficial holders are encouraged to contact their bank, broker or other nominee with any procedural questions. Additional information concerning the reverse stock split can be found in Checkpoint’s definitive Information Statement on Schedule 14C filed with the Securities and Exchange Commission on November 14, 2022.

About Checkpoint Therapeutics
Checkpoint is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers. Checkpoint is evaluating its lead antibody product candidate, cosibelimab, a potential best-in-class anti-PD-L1 antibody licensed from the Dana-Farber Cancer Institute, in an ongoing global, open-label, multicohort Phase 1 clinical trial in checkpoint therapy-naïve patients with selected recurrent or metastatic cancers, including ongoing cohorts in locally advanced and metastatic cutaneous squamous cell carcinoma (“cSCC”) intended to support one or more applications for marketing approval. Following positive topline and interim results in metastatic and locally advanced cSCC, respectively, Checkpoint intends to submit a Biologics License Application for these indications later this year. Checkpoint is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib (formerly CK-101), a third-generation epidermal growth factor receptor (“EGFR”) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer. Checkpoint is headquartered in Waltham, MA and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). For more information, visit

Forward‐Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended, that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements relating to the reverse stock split improving the marketability and liquidity of our common stock and to remain in compliance with Nasdaq’s continued listing requirements, statements relating to the potential differentiation of cosibelimab, including a potentially favorable safety profile as compared to the currently available anti-PD-1 therapies, the two-fold mechanism of action of cosibelimab translating into potential enhanced efficacy, projections of publication and regulatory submission timelines, and our planned price disruptive strategy generating substantial market share for cosibelimab in the U.S. Factors that could cause our real results to differ materially include the following: our ability to successfully deliver the complete dataset from the clinical trial and complete a BLA submission on schedule as planned; the risk that topline and interim data remains subject to audit and verification procedures that may result in the final data being materially different from the topline or interim data we previously published; the risk that safety issues or trends will be observed in the clinical trial when the full safety dataset is available and analyzed; the risk that a positive primary endpoint does not translate to all, or any, secondary endpoints being met; risks that regulatory authorities will not accept an application for approval of cosibelimab based on data from the Phase 1 clinical trial; the risk that the clinical results from the Phase 1 clinical trial will not support regulatory approval of cosibelimab to treat cSCC or, if approved, that cosibelimab will not be commercially successful; risks related to our chemistry, manufacturing and controls and contract manufacturing relationships; risks related to our ability to obtain, perform under and maintain financing and strategic agreements and relationships; risks related to our need for substantial additional funds; other uncertainties inherent in research and development; our dependence on third-party suppliers; government regulation; patent and intellectual property matters; competition; and our ability to achieve the milestones we project, including the risk that the evolving and unpredictable Russia/Ukraine conflict and COVID-19 pandemic delay achievement of those milestones. Further discussion about these and other risks and uncertainties can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and in our other filings with the U.S. Securities and Exchange Commission.

Any forward-looking statements set forth in this press release speak only as of the date of this press release. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. This press release and prior releases are available at

Company Contact:
Jaclyn Jaffe
Checkpoint Therapeutics, Inc.
(781) 652-4500

Investor Relations Contact:
Ashley R. Robinson
Managing Director, LifeSci Advisors, LLC
(617) 430-7577

Media Relations Contact:
Katie Kennedy
Gregory FCA

Mon, 05 Dec 2022 08:20:00 -0600 en-US text/html
Killexams : Bakersfield Police Department to hold DUI Checkpoint at an undisclosed location

BAKERSFIELD, Calif. (KERO) — The Bakersfield Police Department will be on the lookout for drivers under the influence on Friday, December 9th.

There will be a DUI and Driver's License Checkpoint at an undisclosed location in town. The checkpoints are a proven way of reducing the number of people killed or injured in alcohol or drug-involved crashes.

Copyright 2022 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Wed, 07 Dec 2022 02:49:00 -0600 en text/html
Killexams : Dog in backpack accidentally sent through X-ray at Wisconsin airport checkpoint

Airport security staff spotted another small animal inside a U.S. traveler's checked bag this week. While screening luggage as it passed through the X-ray machine at Dane County Regional Airport in Madison, Wisconsin, agents discovered a dog packed into what appeared to be a backpack small enough to fit in one of the security trays, according to the Transportation Security Administration

The agency, which often recounts startling finds by TSA agents working security stations across the country, said the pet "was accidentally sent through" the machine in a message posted on Twitter. The passenger was unaware of screening protocol and did not alert the Transportation Security officers that the small dog — a dachshund/Chihuahua mix — was in a backpack-style carrier, a TSA spokesperson told CBS News. The officer confirmed the passenger had told the airline she was traveling with the dog, and she headed to the gate after her bags were cleared, the TSA spokesperson said.

A tweet from the TSA Great Lakes branch shared Tuesday included side-by-side images of the dog as it appeared on the airport security scanner, and the backpack where it was found.

"When traveling with any animal, notify your airline & know their rules. At the checkpoint, remove your pet from the bag and send all items, including the empty carrier, to be screened in the machine," the tweet sid. The agency also shared a video of an airline passenger traveling with a cat to demonstrate the correct procedure.

"Here's the proper way to travel with your pet," wrote TSA Great Lakes. "Note: This is a @TSA PreCheck passenger traveling with a cat. If you think your pet will attempt an escape, ask to speak with a supervisor before removing the animal. Alternative screening options may be available."

Individual airlines have different protocols for passengers looking to travel with pets. But, typically, most require anyone traveling with a small animal to bring it along in a carrier small enough to remain with the traveler for the duration of their flight. Like the cat owner in TSA's social media video, travelers must be able to remove the pet from the carrier and send the empty bag through the airport's security checkpoint for screening. 

The rules are slightly different for service animals, but no scenarios exist where airline passengers are permitted to travel with unreported pets inside checked baggage.

Wed, 07 Dec 2022 12:31:00 -0600 en-US text/html
Killexams : Travelers in Ben-Gurion Airport told to duck after car breaks through checkpoint

This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.

Sat, 03 Dec 2022 14:56:00 -0600 en-US text/html
CCSPA exam dump and training guide direct download
Training Exams List